S Gobec

No ORCID on file · 5 papers in corpus · active 2008-2011

Study types

  • other 3
  • review 2

Condition tags

  • endometriosis 5
other 2011
Chemico-biological interactions ·doi:10.1016/j.cbi.2011.01.002

Human 17β-hydroxysteroid dehydrogenase (17β-HSD) type 1 is an enzyme that acts at the pre-receptor level. It catalyzes the NADPH-dependent reduction of the weak estrogen estrone into the most potent estrogen 17β-estradiol, which exerts prol…

review 2011
Current medicinal chemistry ·doi:10.2174/092986711795933713

The AKR1C aldo-keto reductases (AKR1C1-AKR1C4) are enzymes that interconvert steroidal hormones between their active and inactive forms. In this manner, they can regulate the occupancy and trans-activation of the androgen, estrogen and prog…

other 2011
Chemico-biological interactions ·doi:10.1016/j.cbi.2010.12.012

The human aldo-keto reductases 1C1 and 1C3 (AKR1C1 and AKR1C3) are important 20-ketosteroid reductases in pre-receptor regulation of progesterone action. Both AKR1C1 and AKR1C3 convert progesterone to the less potent metabolite 20α-hydroxyp…

other 2009
Chemico-biological interactions ·doi:10.1016/j.cbi.2008.10.019

Human hydroxysteroid dehydrogenase (HSD) AKR1C1 is a member of the aldo-keto reductase superfamily, and it functions mainly as a 20alpha-HSD. It catalyzes the reduction of the potent progesterone to the weak 20alpha-hydroxyprogesterone, and…

review 2008
Current medicinal chemistry ·doi:10.2174/092986708783330629

Carcinogenesis of hormone-related cancers involves hormone-stimulated cell proliferation, which increases the number of cell divisions and the opportunity for random genetic errors. In target tissues, steroid hormones are interconverted bet…